Department of Clinical Pharmacy

The robotic pharmacy at the UCSF Medical Center is the recipient of a 2011 Best of What’s New (Archived) designation by Popular Science.

The office of Lisa Bero, PhD, on UCSF’s Laurel Heights campus has long been a key portal between the School of Pharmacy and the world at large, including countries where billions of people cannot get even the most vital life-saving drugs.

Michael Nordberg, MPA/HSA, is the newly appointed associate dean of administration and finance for the UCSF School of Pharmacy.

An analysis by UCSF faculty members from the Schools of Pharmacy and Medicine has found that the half-dozen most reputable electronic drug information resources—tools commonly used by clinicians to make prescription and patient monitoring decisions—may not provide key elements of some medications’...

Michael Williams, MA, is the first executive director of academic, administrative, and research technology for the UCSF School of Pharmacy, effective August 1, 2011.

Faculty awards: Cutler, Fujimori, Huang, Wells. New faculty members: Abate, VanOsdol, Rodondi. Retiring faculty members: Kahl, Shafer, Wang, Kayser, Koo. PharmD students: Campbell, Wheeler, Ho, Lam, Campbell, Loucks, Marotto, Huynh, Luu, Chua, Stephens. PhD students: Gray. New appointments: Penick...

The 2nd Annual Bay Area Biotechnology Symposium, presented by the UCSF School of Pharmacy’s Industry Outreach Program in coordination with the UCSF Postdoctoral Scholars Association at Mission Bay in late May 2011, fully lived up to its billing: “Pharmaceuticals of the Futur

William Soller, PhD, and Marilyn Stebbins, PharmD, faculty members in the UCSF School of Pharmacy’s Department of Clinical Pharmacy, were sources for a July 25, 2011 Los Angeles Times feature about the safety and effectiveness of saving money by splitting pills or taking medications after their...

Magnetic resonance imaging (MRI), used with a novel pyruvate chemical compound that is specially labeled to be read by the MRI machine, is being applied for the first time in humans to study the aggressiveness of prostate cancer in patients and the success of prostate cancer therapies.

A study by researchers with the UCSF School of Pharmacy, Department of Clinical Pharmacy finds that the Medicaid program is likely paying far more than necessary for medications and not offering patients the most effective ones available.